Farxiga (dapagliflozin) is used to treat several heart-related conditions, not just diabetes.
What heart problems is Farxiga used for?
Farxiga is prescribed for heart failure and to help reduce the risk of heart-related outcomes in certain patients with heart disease. It is used for:
- Heart failure with reduced ejection fraction (HFrEF) (to improve outcomes and reduce risk of hospitalization and death).
- Heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) in appropriate patients (to reduce risk of hospitalization for heart failure).
- Chronic kidney disease and/or cardiovascular risk reduction settings where heart protection applies, depending on the patient’s overall condition and clinician judgment.
Is Farxiga for people who do not have diabetes?
Yes. Farxiga can be used for heart failure even when a person does not have diabetes, because its heart-failure benefit comes from how it affects fluid balance and kidney/vascular pathways rather than from insulin/glucose control alone.
How does it help with heart failure?
Farxiga is a type of medication called an SGLT2 inhibitor. In heart failure, it helps reduce the strain on the heart partly by:
- Promoting the loss of glucose and sodium through the urine, which can also reduce fluid overload.
- Improving kidney function in ways that support overall cardiovascular stability.
What should patients watch for?
Patients starting Farxiga for heart problems are typically monitored for known SGLT2-inhibitor risks, which can include:
- Dehydration or low blood pressure (especially if they’re already on diuretics or have low baseline blood pressure).
- Genital yeast infections.
- Rare but serious infections and, in some cases, signs of diabetic ketoacidosis even with normal or only mildly elevated glucose (risk is higher with certain situations like prolonged fasting, heavy alcohol use, or acute illness).
If you tell me the specific “heart problem” you mean (heart failure? reduced pumping function? coronary artery disease? someone’s discharge diagnosis?) and whether the patient has diabetes, I can map Farxiga’s typical use more precisely.